1. Home
  2. OVV vs MEDP Comparison

OVV vs MEDP Comparison

Compare OVV & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovintiv Inc. (DE)

OVV

Ovintiv Inc. (DE)

HOLD

Current Price

$62.70

Market Cap

20.0B

Sector

Energy

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$656.77

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVV
MEDP
Founded
2020
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Commercial Physical & Biological Resarch
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.0B
17.2B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
OVV
MEDP
Price
$62.70
$656.77
Analyst Decision
Buy
Hold
Analyst Count
27
14
Target Price
$81.52
★ $651.31
AVG Volume (30 Days)
★ 3.2M
294.0K
Earning Date
11-03-2026
10-21-2026
Dividend Yield
★ 1.81%
N/A
EPS Growth
13.54
★ 20.98
EPS
1.36
★ 13.37
Revenue
★ $8,908,000,000.00
N/A
Revenue This Year
$18.95
$12.62
Revenue Next Year
N/A
$6.03
P/E Ratio
★ N/A
$49.80
Revenue Growth
N/A
★ N/A
52 Week Low
$36.81
$373.00
52 Week High
$73.62
$693.97

Technical Indicators

Market Signals
Indicator
OVV
MEDP
Relative Strength Index (RSI) 46.77 57.79
Support Level $56.66 $575.64
Resistance Level $67.45 $677.90
Average True Range (ATR) 2.23 22.98
MACD -0.35 0.50
Stochastic Oscillator 9.68 63.68

Price Performance

Historical Comparison
OVV
MEDP

About OVV Ovintiv Inc. (DE)

Ovintiv is an independent oil and gas producer focused on Canada's Montney and the US' Permian basins. Historically, it has been an acquisitive producer across numerous basins and plays but has divested and exited all but two. It remains an active buyer in the remaining footprint. The firm estimates that it has up to 20 and 15 years of inventory remaining in the Montney and Permian basins, respectively.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: